Spectral Medical - SDI Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: C$0.35
  • Forecasted Upside:
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
C$0.00
+0 (0.00%)

This chart shows the closing price for SDI by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Spectral Medical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SDI and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SDI

Analyst Price Target is C$0.35
▲ +∞ Upside Potential
This price target is based on 0 analysts offering 12 month price targets for Spectral Medical in the last 3 months. The average price target is C$0.35, with a high forecast of C$0.35 and a low forecast of C$0.35. The average price target represents a ∞ upside from the last price of C$0.00.

This chart shows the closing price for SDI for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in Spectral Medical. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/24/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/22/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/22/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/21/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/19/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/17/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/17/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/16/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/24/2023Stifel NicolausLower TargetC$0.40 ➝ C$0.35
6/15/2023Stifel NicolausLower TargetC$0.45 ➝ C$0.40
5/16/2023Stifel NicolausLower TargetC$0.50 ➝ C$0.45
3/17/2023Stifel NicolausLower TargetC$0.65 ➝ C$0.55
11/14/2022Stifel NicolausLower TargetC$0.75 ➝ C$0.65
8/24/2022Stifel NicolausBoost TargetC$0.65 ➝ C$0.70
7/8/2022Stifel NicolausInitiated CoverageBuyC$0.65
(Data available from 4/16/2019 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/18/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/18/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/17/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/17/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/16/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/15/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/16/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/15/2024

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Spectral Medical logo
Standard Diversified, Inc. is a holding company, which owns and operates subsidiaries in a variety of industries, including other tobacco products, insurance, and outdoor advertising. It operates through the following segments: Smokeless Products, Smoking Products, and NewGen Products. The Smokeless Product segment manufactures and markets moist snuff and contracts for and markets chewing tobacco products. The Smoking Products segment imports and markets cigarette papers, tubes, and related products; imports and markets finished cigars, MYO cigar tobaccos, and cigar wraps; and processes, packages, and markets pipe tobaccos. The NewGen Products segment trades e-cigarettes, e-liquids, vaporizers, and other related products; and distributes a wide assortment of vaping products to non-traditional retail outlets via VaporBeast and Vapor Shark. The company was founded by Martha C. Reider, Anne Cavanaugh and Richard C. Birkmeyer in 1990 and is headquartered in New York, NY.
Read More

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

N/A

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Spectral Medical?

The following Wall Street research analysts have issued research reports on Spectral Medical in the last year: Stifel Nicolaus.
View the latest analyst ratings for SDI.

What is the current price target for Spectral Medical?

1 Wall Street analysts have set twelve-month price targets for Spectral Medical in the last year. Their average twelve-month price target is C$0.35. Stifel Nicolaus has the highest price target set, predicting SDI will reach C$0.35 in the next twelve months. Stifel Nicolaus has the lowest price target set, forecasting a price of C$0.35 for Spectral Medical in the next year.
View the latest price targets for SDI.

What is the current consensus analyst rating for Spectral Medical?

Spectral Medical currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for SDI.

How do I contact Spectral Medical's investor relations team?

Spectral Medical's physical mailing address is 767 5th Avenue, New York, NY 10153. The company's listed phone number is 1.516.248.1100. The official website for Spectral Medical is www.standarddiversified.com. Learn More about contacing Spectral Medical investor relations.